Recently, sirt3 was reported to contribute to the improvement of metabolic reprogramming and endothelial-to-mesenchymal transition (EndMT) in endothelial cells of DN, leading to the amelioration of fibrosis (Srivastava et al., 2021a). This evidence concerns the gene SIRT3 and liver dysplastic nodule.